HighTower Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-234
Closed -$3.98K 3767
2023
Q3
$3.98K Buy
+234
New +$25.2K ﹤0.01% 3439
2022
Q4
Sell
-1
Closed -$1K 3445
2022
Q3
$1K Buy
+1
New +$89 ﹤0.01% 3122
2022
Q1
Sell
-1
Closed -$4K 3574
2021
Q4
$4K Sell
1
-99
-99% -$7.88K ﹤0.01% 3206
2021
Q3
$1K Buy
+100
New +$7.61K ﹤0.01% 3136

Other funds holding MRK

HighTower Advisors's MRK Position: Q2 2026 in Review

HighTower Advisors increased its Merck (MRK) stake by 1.2% in Q2 2026, buying an estimated $5.21M and bringing the position to 3,679,920 shares worth $473M. The position accounts for 0.45% of the portfolio, ranked #40.

HighTower Advisors first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • HighTower Advisors held 3,679,920 shares of Merck worth $473M as of Q2 2026.
  • HighTower Advisors bought 44,516 Merck shares in Q2 2026, an estimated $5.21M.
  • Merck made up 0.45% of HighTower Advisors's portfolio in Q2 2026, its #40 holding.
  • HighTower Advisors first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.